Tumour heterogeneity for differentiation between tumour and normal liver tissue in FDG-PET imaging

被引:0
|
作者
Jaritz, L. [1 ]
Ahmadzadehfar, H. [1 ]
Essler, M. [1 ]
Zsoter, N. [2 ]
Papp, L. [2 ]
Gaertner, F. [1 ]
Bundschuh, R. A. [1 ]
Thomas, L. [1 ]
机构
[1] Univ Klinikum Bonn, Dept Nucl Med, Bonn, Germany
[2] Mediso Med Imaging Syst, Budapest, Hungary
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP457
引用
收藏
页码:S189 / S190
页数:2
相关论文
共 50 条
  • [21] Volume of abnormal tumour tissue on FDG-PET - a predictor of progression-free survival in Hodgkin lymphoma?
    Hutchings, M
    Berthelsen, AK
    Jakobsen, AL
    Specht, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S45 - S45
  • [22] Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer
    Schurink, Niels W.
    van Kranen, Simon R.
    Berbee, Maaike
    van Elmpt, Wouter
    Bakers, Frans C. H.
    Roberti, Sander
    van Griethuysen, Joost J. M.
    Min, Lisa A.
    Lahaye, Max J.
    Maas, Monique
    Beets, Geerard L.
    Beets-Tan, Regina G. H.
    Lambregts, Doenja M. J.
    EUROPEAN RADIOLOGY, 2021, 31 (09) : 7031 - 7038
  • [23] High resolution PET imaging of tumour using (18)FDG
    Hastings, DL
    Moore, JV
    Waller, ML
    Acton, PD
    Dodd, NJ
    Hand, JC
    Nuttall, PM
    Jeavons, AP
    QUANTITATIVE IMAGING IN ONCOLOGY: 19TH L H GRAY CONFERENCE, 1996, : 9 - 13
  • [24] The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning
    van Baardwijk, Angela
    Baumert, Brigitta G.
    Bosmans, Geert
    van Kroonenburgh, Marinus
    Stroobants, Sigrid
    Gregoire, Vincent
    Lambin, Philippe
    De Ruysscher, Dirk
    CANCER TREATMENT REVIEWS, 2006, 32 (04) : 245 - 260
  • [25] Usefulness of Combined FDG-PET with CT or Tumour Markers in Lung Cancer Diagnosis
    Kley, Konstantin
    Oehr, Peter
    ANTICANCER RESEARCH, 2010, 30 (05) : 1741 - 1745
  • [26] Impact of intensity discretization on textural indices of [18F]FDG-PET tumour heterogeneity in lung cancer patients
    Forgacs, Attila
    Beresova, Monika
    Garai, Ildiko
    Lassen, Martin L.
    Beyer, Thomas
    DiFranco, Matthew D.
    Berenyi, Ervin
    Balkay, Laszlo
    PHYSICS IN MEDICINE AND BIOLOGY, 2019, 64 (12):
  • [27] Measurement of tumour lesion glycolysis by FDG-PET in triple negative breast cancer
    Tharayil, I. Antony
    Harada, N.
    Patel, N.
    Varghese, V.
    Kenny, L.
    CANCER RESEARCH, 2013, 73
  • [28] Evaluating tumour response of NSCLC patients with FDG-PET: potential for treatment individualisation
    Toma-Dasu, I.
    Uhrdin, J.
    Dasu, A.
    Carvalho, S.
    Van Elmpt, W.
    Lambin, P.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S105 - S105
  • [29] Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging
    Boellaard, Ronald
    O'Doherty, Mike J.
    Chiti, Arturo
    Krause, Bernd J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (07) : 1432 - 1433
  • [30] Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging
    Ronald Boellaard
    Mike J O’Doherty
    Arturo Chiti
    Bernd J. Krause
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1432 - 1433